Mainz Biomed BV (MYNZ) Financials

$0.47

$-0.37 (-43.85%)

As on 09-Apr-2026 09:30EDT

Market cap

$11 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

10.5

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	-10.98	-17.09	-21.94	-14.77	-3.22	-0.47
Cash Flow from Investing Activities	-1.03	-0.20	-1.90	-0.66	1.20	-0.01
Cash from Financing Activities	6.76	16.60	14.23	23.94	10.61	0.40
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-2.70	-22.36	-49.70	-3.67	-1.62	-0.03
Cash EPS ($)	-2.60	-21.31	-48.06	-3.62	-1.61	-0.02
Adjusted Book Value ($)	0.11	6.25	6.14	1.95	0.88	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-1.83	-17.65	-41.46	-2.05	-0.45	-0.02
Free Cash Flow per Share ($)	-1.83	-17.91	-45.05	-2.14	-0.45	-0.02

Profitability Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	-258.73	-216.64	-187.86	-201.45	-254.81	-167.34
ROE (%)	-484.76	-465.82	-303.20	-258.62	-645.93	25.02
ROA (%)	-174.63	-151.15	-147.52	-174.71	-218.22	-84.49
EBIT Margin (%)	-2,513.37	-2,301.53	-2,908.58	-4,940.32	-1,966.05	-83.17
Net Margin (%)	-3,018.31	-2,421.80	-2,936.50	-4,992.24	-2,024.79	-118.91
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	-0.40	0.00	0.69	-0.08	0.17	0.75
EBIT Growth (%)	34.39	21.00	0.50	-130.62	-2,665.30	45.64
Net Profit Growth (%)	25.13	17.66	0.59	-126.28	-1,891.86	38.68
EPS Growth (%)	0.88	0.55	-12.55	-1.26	-63.69	0.69
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	-0.41	-0.19	-0.02	-1.94	-6.41	--
Price / Book Value	10.47	0.69	0.19	3.63	11.78	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.65	-0.06	-0.04	-1.45	-6.10	--
Close Price ($)	1.12	4.32	46.40	284.00	415.60	--
High Price ($)	8.20	48.80	314.00	1,200.00	720.00	--
Low Price ($)	0.92	3.65	40.00	242.40	200.00	--
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	4.01	0.54	2.28	0.23	0.41	-1.09
Short term debt to equity ratio	2.46	0.40	1.61	0.09	0.04	-0.10
Current Ratio	0.50	1.32	0.97	4.33	7.11	0.27
Quick Ratio	0.44	1.26	0.91	4.29	645.64	--
Interest Coverage	-36.15	-19.14	-32.17	-90.48	-33.47	-1.53

Operating Efficiency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	20.65	23.91	39.59	48.91	3.08	8.96
Asset Turnover	0.06	0.06	0.05	0.03	0.11	0.71
Receivable days	110.39	116.08	125.15	95.43	19.61	31.47
Inventory Days	141.16	564.58	373.52	-453,227.34	-788,695.13	--
Payable days	401.93	2,049.19	1,732.19	1,137.35	469.64	194.95
Cash Conversion Cycle	-150.39	-1,368.53	-1,233.52	-454,269.25	-789,145.15	--